Seperately Filed Delaying Amendment Under Securities Act Rule 473 to Delay Effectiveness of a 1933 Act Registration Statement...
October 17 2018 - 6:06AM
Edgar (US Regulatory)
Sunshine Biopharma Inc.
6500 Trans-Canada Highway, 4th Floor
Pointe-Claire, Quebec, Canada H9R 0A5
(514) 426-6161
October 16, 2018
VIA EDGAR
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Re:
|
Sunshine Biopharma Inc. -
Registration Statement on Form S-1 (File No.
333-227748
)
|
Ladies and Gentlemen:
Pursuant to Rule 473(c) of the Securities Act of 1933 (the
“Act”), the following delaying amendment, prescribed by
Rule 473(a) of the Act, is hereby incorporated into the facing page
of the Registration Statement on Form S-1 (File No. 333-227748)
filed by Sunshine Biopharma Inc. with the Securities and Exchange
Commission on October 9, 2018:
“The Registrant hereby amends this
Registration Statement on such date or dates as may be necessary to
delay its effective date until the Registrant shall file a further
amendment which specifically
states that this registration statement shall
thereafter become effective in accordance with section 8(a) of the
Securities Act of 1933, as amended, or until the Registration
Statement shall become effective on such date as the Securities and
Exchange Commission acting pursuant to said Section 8(a), may
determine.”
Should you have any questions regarding the Registration Statement,
please feel free to contact Dr. Steve N. Slilaty at (514)
426-6161.
|
Very
truly yours,
|
|
|
|
|
|
SUNSHINE BIOPHARMA INC.
|
|
|
|
|
|
/s/ Dr. Steve N. Slilaty
|
|
|
Dr.
Steve N. Slilaty
|
|
|
Chief
Executive Officer
|
|